HCV News
The team from the Indian Institute of Science (IISc), Bengaluru, has developed a vaccine for HCV genotype 3a.
Since Hepatitis C is under-diagnosed in India and diagnosis is expensive, the scientists will work to identify a group of people who are in need of treatment.
Recently approved antiviral medications for hepatitis C could reduce the prevalence of the blood-borne infection by more than 80 percent, researchers have estimated.
Importantly, for the first time, researchers can use urine specimens for one-step screening and diagnosing of HCV infection.
Loading...